Eight patients with AIDS and Pneumocystis carinii infection were studied. Protean manifestations were a feature not untypical of disseminated pneumocystosis. Aerosolised pentamidine as prophylaxis against P carinni pneumonia was ineffective at suppressing dissemination. The knowledge that extrapulmonary infection can occur has implications for the detection and treatment of, and prophylaxis against, P carinji infection. The survival of patients with disseminated pneumocystosis is particularly poor, and may be due to a lack of clinical awareness and consequent delay in diagnosis.
A 36 year old homosexual man presented with a three week history of perianal pain. He had been reported as HIV-1 antibody positive two years previously (July 1987) when he was diagnosed as having P carinii pneumonia. P carinii pneumonia recurred in November 1988 in conjunction with pulmonary tuberculosis. Details ofthe treatment he received in the USA for these episodes are not available, but he subsequently received aerosolised pentamidine (300 mg fortnightly) as secondary prophylaxis. He had had recurrent perianal herpes and developed cryptosporidial diarrhoea in July 1989. Examination showed that he was emaciated, feverish (39°G), and had oral candidosis and hairy oral leucoplakia. He had a right sided pneumothorax, evidence of cytomegalovirus infection (CMV), retinitis and a 2 cm ulcerated necrotic perianal mass, which was excised. He developed a left pneumothorax and despite treatment deteriorated and died shortly afterwards. CASE 
2
A 26 year old homosexual man presented with severe abdominal pain. A chest x ray picture on admission showed bilateral pulmonary infiltrates suggestive of P carinii pneumonia. He had been found to be HIV antigen and antibody positive two years previously (November 1988) . Mycobacterium malmoense had been isolated from sputum samples in June 1990 and at that time he had started quadruple anti-tuberculous treatment. He had developed an enlarged non-tender thyroid six weeks before admission and was found to be hypothyroid for which he was being treated with thyroxine. Auto-antibodies were not detected. He had received aerosolised pentamidine (300 mg fortnightly) as prophylaxis against P carinii pneumonia for six months. At laparotomy a perforation of the small bowel was found and repaired, but he died seven days later.
CASE 32
A 33 year old homosexual man presented with a history of weight loss, anorexia, dry cough, fever and night sweats. He had been found to be HIV-1 antibody positive three years previously and had developed P carinii pneumonia two years and again 10 months before admission. Since his first episode ofP carinii pneumonia he had been maintained on aerosolised pentamidine (300 mg fortnightly). He was feverish (39-4°C) and cachectic. His chest and abdomen were clinically normal, as were chest x ray picture and arterial blood gas analysis. Bronchoscopy 
CASE 8
Both lungs showed yellow cavitating consolidation (left weighing 800 g, right weighing 1050 g), and the hilar nodes showed yellow infiltration. The remaining organs were macroscopically normal. Histologically, the lung and nodes showed calcifying P carinii infection. P carinii and a focal granulomatous reaction had infiltrated and occluded the arteries of the lungs. CMV infection was present only in the adrenal glands. alveoli in P carinii pneumonia in haematoxylin and eosin stained sections. In cases 1, 3, and 6 the exudate was very scanty and only visible in some of the levels which were cut completely through the specimens. Microscopically, case 2 had a necrotic tumour (2-5 cm in diameter) protruding into the lumen of the small bowel, with a perforation (0 3 cm in diameter) close to its base. This was Kaposi's sarcoma, but much of the tumour had been replaced by the foamy exudate described above, particularly in the region ofthe perforation (fig 1) . Numerous cells infected with CMV were also present within the tumour. The combination of P carinii, CMV, and Kaposi's sarcoma was also seen in case 1. In all cases the diagnosis was confirmed by demonstrating the cyst forms of P carinii using Grocott's methenamine silver stain ( fig  2) . In case 4 the only evidence of P carinii infection was the presence of cyst forms in hepatic sinusoids on Grocott's methenamine silver stain.
Post mortem findings CASE 2 The lungs (left weighing 700 g, right weighing 650 g; normal values, left 570 g, right 620 g) were consolidated and contained a yellow nodule, 2 cm in diameter. Similar yellow tissue infiltrated the chest, mesenteric lymph nodes, and the thyroid, which was completely replaced. Small yellow nodules were present in the liver, spleen, and kidneys. Histologically, the yellow infiltrates represented P carinii infection with calcification. The intestine showed no residual P carinii lesions. The pneumonic consolidation represented shock lung (adult hyaline membrane disease). CMV infection was found only in the adrenal glands. CASE 7 Lymphoma was found in the brain and left lung (right and left weighing 600 g). There was widespread P carinii pneumonia with cavitation, and the P carinii was intermingled with the lymphoma. The sinuses of the hilar lymph nodes were infiltrated by P carinii, but not by lymphoma. Histologically, there was much Discussion Dissemination of P carinii infection is rare, but is increasingly being reported in patients with AIDS. This series includes: the first patients to be reported with perianal infection; the first patient to develop hypothyroidism secondary to P carinii thyroiditis; the first patient to develop bowel perforation; and the first reported cytological documentation of P carinii in pleural fluid in the absence of concurrent ipsilateral pneumothorax.
Of the 585 episodes of P carinii infection (397 patients) treated at St Mary's and the Middlesex Hospitals up to November 1990, only these eight (0 5%) patients had evidence of extrapulmonary spread. The incidence of disseminated P carinii infection documented here is lower than that reported previously, but the incidence of clinical disease is similar. In a review of 161 necropsies of patients with AIDS, 55 had P carinii pneumonia; four (2 5 %) had extrapulmonary P carinii infection, but only one had clinical evidence of this.3 Extrapulmonary sites in which P carinii infection has been documented include the spleen,4 liver,35 kidney,3 4 Perianal disease as a result of P carinii infection has not previously been reported, although associated disease of the oesophagus, duodenum, appendix, jejunum and thyroid have.478 The hypothyroidism noted in case 2 several weeks before his final admission was probably caused by infection in this organ. This patient also had a perforation of his small bowel. This has not previously been associated with pneumocystosis, but, histologically, the extensive pneumocystis infection seemed to be the cause of the perforation, although the coexistent CMV infection may also have played a part.'314 There are no reports of Kaposi's sarcoma with perforation in cases of AIDS without CMV infection,2 implying that Kaposi's sarcoma is not destructive enough to cause perforation of the gastrointestinal tract.
Colonisation of the liver by P carinii (cases 2, 3, and 4) is commonly seen when dissemination occurs. Six of the 10 cases reviewed by Northfelt'5 had some hepatic disease although none developed hepatic failure. Jenkins et al, '6 reporting on case 3, have discussed the occurrence of unrecognised P carinii hepatitis and resultant hepatic failure.
In case 5 pneumocysts were isolated from the pleural effusion on the contralateral side to the pneumothorax. Though pleural effusions in P carinii pneumonia'7 and isolation of P carinii from the pleura have been reported,'8 we are unaware of pneumocysts being isolated from this site unless there is concurrent ipsilateral pneumothorax. '9 There has recently been concern over the use of pentamidine possibly being responsible for the increased incidence of pneumothoraces.20 This was noted in cases 1, 5, and 8, all of whom were receiving aerosolised pentamidine.
Six of the eight patients presented here had received aerosolised pentamidine (through Respigard II nebulisers) as either primary (cases 2 and 6) or secondary (cases 1, 3, 7, and 8) prophylaxis for P carinii pneumonia. The usual portal of entry of P carinii is the lung, and aerosolised pentamidine is attractive because high concentrations can be attained in the lungs, it is well tolerated, and has not resulted in clinically important toxicity. It may be, however, that aerosolised pentamidine is an effective prophylactic agent against pneumonia but ineffective in preventing dissemination of the infection. Moreover, the absence of pneumonia may cause the diagnosis of extrapulmonary pneumocystosis to be overlooked. Dissemination could occur during the initial infection but the occurrence in two cases receiving primary prophylaxis means that the extrapulmonary spread does not only occur during the first clinical episode of P carinii pneumonia in AIDS, and that the use of aerosolised pentamidine, though an effective agent for prophylaxis for pneumonia, is ineffective at suppressing extrapulmonary pneumocystosis.1621 This may be relevant when choosing prophylaxis in the future.
In summary, the cases reported here show the protean manifestations of disseminated pneumocystosis. Physicians must be aware of the unusual sites of infection, especially in patients not receiving any prophylaxis or receiving prophylaxis in the form ofaerosolised pentamidine. Pathologists should be alerted to look specifically for pneumocysts in biopsy samples from HIV antibody positive patients whatever the tissue, because earlier diagnosis and systemic treatment may improve survival.
